Flaminal^® and Flaminal^® RT are advanced wound care dressings designed to effectively manage the complex skin reactions caused by radiotherapy. Ionizing radiation damages the hereditary material in the cell nuclei of the skin, leading to cell death during subsequent cell divisions. While symptoms may not be visible during the first few weeks, by the third week, patients often experience varying degrees of radiodermatitis.

Types of Radiodermatitis and Their Symptoms

Radiodermatitis can progress from mild redness and skin tightness to more severe conditions, such as moist desquamation with fluid exudate. As the condition worsens, symptoms like itching, soreness, and swelling become more intense. The stages of radiodermatitis are categorized as follows:

RTOG 1

• Faint or dull erythema
• Mild tightness of the skin
• Itching may occur

RTOG 2A

• Bright erythema
• Dry desquamation
• Sore, itchy and tight skin

RTOG 2B

• Patchy, moist desquamation
• Yellow or pale green exudate
• Soreness and oedema

RTOG3

• Confluent, moist desquamation
• Yellow or pale green exudate
• Soreness with oedema

Use of Flaminal^®

Flaminal^® provides an effective treatment for RTOG2B and RTOG3 dermatitis offering a gentle yet powerful approach to managing radiotherapy-induced wounds. Its advanced enzyme system helps to protect against infection, continuously debrides the wound, and absorbs excess exudate.

Flaminal^® is an advanced wound dressing that supports faster wound healing and helps improve the quality of life for patients undergoing radiotherapy, particularly those with severe skin reactions such as bloody lesions.

Download this brochure to learn more about the radiodermatitis treatment process and the Flamigel^® RT and Flaminal^® treatment pathways.